Hiroshi Nomoto

42PUBLICATIONS
47CO-AUTHORS
Population trends and policiesPredictive and prognostic markersPharmacogenomicsMetabolic medicineBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Sep 30, 2026
Renal function trajectories before and during the COVID-19 pandemic in Japanese individuals with type 1 diabetes: a post-hoc analysis of the multicenter retrospective investigation by the IPRA-CKD study group.

|Sep 25, 2026
Linagliptin increases the expression of LRP2 independent of Nrf2 in streptozotocin-induced diabetic mice.

|Sep 25, 2026
Effect of pemafibrate on LDL-cholesterol properties in type 2 diabetes and hypertriglyceridemia by lipid management status: PARM-T2D post hoc analysis.

|Aug 05, 2026
Relationship between Metabolic Remodeling of Pancreatic β-cells and Pancreatic Histology in Type 2 Diabetes.

|Jul 15, 2026
Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters.

|Jun 15, 2026
Effectiveness of tirzepatide in Japanese patients with type 2 diabetes but no obesity: A sub-analysis of Hokkaido-TZP study data.

Pageof 7

Frequent Collaborators

19 joint publications

Akinobu Nakamura

14 joint publications

Hiraku Kameda

11 joint publications

Aika Miya

11 joint publications

Kyu Yong Cho